iX Biopharma Ltd. announced that on May, 6 2026 it allotted 143,572 new ordinary shares following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share.
With the issuance, the company’s share count increased to 1,050,895,596 from 1,050,752,024.
The new shares will rank pari passu with existing shares and are expected to start trading on the Singapore Exchange on or around May, 8 2026.
To date, 20.14 million warrants—35.01% of all warrants originally issued—have been exercised. A total of 37.37 million warrants remain outstanding, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.